Could Fampridine Attenuate the Severity of COVID-19 in Patients with Multiple Sclerosis?

  • Abdorreza Naser Moghadasi Multiple Sclerosis Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.
  • Nassim Anjidani Medical Department, Orchid Pharmed Company, Tehran, Iran.
  • Fereshteh Rashvand OrchidLife Patient Support Service, Orchid Pharmed, Tehran, Iran.

Abstract

The article's abstract is not available.  
Published
2021-04-04
Section
Articles